The charity is slashing £45 million from its research budget
Category: Uncategorized
Updated Date: Mon, 30 Nov 2020 00:00:00 EST
Updated Date: Mon, 30 Nov 2020 00:00:00 EST
Updated Date: Mon, 30 Nov 2020 00:00:00 EST
Updated Date: Mon, 30 Nov 2020 00:00:00 EST
Updated Date: Mon, 30 Nov 2020 00:00:00 EST
ASH: Gilead’s CAR-T med Yescarta shows promise earlier in lymphoma therapy chelfand Mon, 12/07/2020 – 14:53
ASH: Takeda pads case for new leukemia use with 5-year survival data chelfand Mon, 12/07/2020 – 17:43
FDA promo watchdog dings Azurity for misleading leukemia drug email targeting physicians bbulik Mon, 12/07/2020 – 11:09
A new approach to cancer therapy shows potential to transform the commonly used chemotherapy drug gemcitabine into a […]